Scorpius Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCPX research report →
Companywww.scorpiusbiologics.com
Scorpius Holdings Inc. , through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies.
- CEO
- Jeffrey Alan Wolf
- IPO
- 2013
- Employees
- 90
- HQ
- Morrisville, NC, US
Price Chart
Valuation
- Market Cap
- $12.39K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 6.10%
- Op Margin
- -2538.18%
- Net Margin
- -1793.26%
- ROE
- 427.81%
- ROIC
- -48791205.78%
Growth & Income
- Revenue
- $6.24M · -10.75%
- Net Income
- $-32,807,843 · 27.44%
- EPS
- $-13.04 · 96.24%
- Op Income
- $-33,600,261
- FCF YoY
- 19.80%
Performance & Tape
- 52W High
- $0.15
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -5.64
- Avg Volume
- 22.50K
Get TickerSpark's AI analysis on SCPX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 3, 25 | Thuan Tan Sze | other | 0 |
| May 16, 24 | Wolf Jeffrey Alan | other | 2,500,000 |
| May 16, 24 | Wolf Jeffrey Alan | other | 2,500,000 |
Our SCPX Coverage
We haven't published any research on SCPX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SCPX Report →